Trial Details
Not RecruitingBasic Information
| Clinical ID | c5095 |
|---|---|
| Identifier | EUCTR2015-002496-26-DE |
| Trial Title | A phase 3b, randomized, controlled, multicentre study with oral ferric maltol (Feraccru) or intravenous iron (ferric carboxymaltose; FCM), for the treatment of iron deficiency anaemia in subjects with inflammatory bowel disease - ST10 versus IV iron for I |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Iron deficiency anaemia with inflammatory bowel disease . MedDRA version: 20.0. Level: LLT. Classification code 10002062. Term: Anaemia iron deficiency |
| Interventions | Trade Name: Feraccru Product Name: Ferracru Product Code: ST10 Pharmaceutical Form: Capsule, hard INN or Proposed INN: Ferric maltol CAS Num |
Participant Information
| Sponsor | Shield TX (UK) Ltd. |
|---|---|
| City | NULL |
| Country/Region | France;United States;Hungary;Belgium;Spain;Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |